■ 英語タイトル：Antibiotics Market Report 2023-2033 : Forecasts by Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), by Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-ACA, Others), by Gender (Male, Female), by Age Group (0-14 Years, 15-54 Years, 55 Years and Over), by Route of Administration (Oral, Intravenous, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

■ 発行会社/調査会社：visiongain ■ 商品コード：VGA23FB018 ■ 発行日：2023年1月31日 ■ 調査対象地域：グローバル ■ 産業分野：医薬品 ■ ページ数：388 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

The Antibiotics Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The global antibiotics market is anticipated to grow owing to the rise in the prevalence of infectious diseases. In addition, the demand is being fuelled by the emergence of innovative methods for new antibiotics for treating bacterial infections, as well as a large number of clinical trials. However, the industry is expected to be hampered by the rise of antibiotic resistance, which is fuelled by antibiotic abuse, as well as the time it takes for regulatory approval. On the other hand, market players across the value chain should expect major profit potential from the development of advanced prospect molecules & novel combination therapies to treat antibiotic-resistant microbial (AMR) infections.

What Questions Should You Ask before Buying a Market Research Report?
• How is the antibiotics market evolving?
• What is driving and restraining the antibiotics market?
• How will each antibiotics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each antibiotics submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading antibiotics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the antibiotics projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
antibiotics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the antibiotics market?
• Where is the antibiotics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the antibiotics market today, and over the next 10 years:
• Our 388-page report provides 144 tables and 223 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the antibiotics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Action Mechanism
• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• DNA Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Others

Drug Class
• Cephalosporin
• Penicillin
• Fluoroquinolone
• Macrolide
• Carbapenem
• Aminoglycoside
• Sulfonamide
• 7-ACA
• Others

Gender
• Male
• Female

Age Group
• 0-14 years
• 15-54 years
• 55 years and over

Route of Administration
• Oral
• Intravenous
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 30 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Denmark
• Norway
• Sweden
• Finland
• Netherlands
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• Singapore
• Malaysia
• Sri Lanka
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Antibiotics Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abbott Laboratories
• Allergan (AbbVie Inc.)
• Amneal Pharmaceuticals LLC
• Cipla Ltd.
• Cumberland Pharmaceuticals, Inc.
• F. Hoffmann-La Roche Ltd.
• GSK plc
• Lupin
• Melinta Therapeutics LLC
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• Viatris, Inc.
• WOCKHARDT

Overall world revenue for Antibiotics Market, 2023 to 2033 in terms of value the market will surpass US$46,575 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Antibiotics Market, 2023 to 2033 report help you?
In summary, our 380+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Antibiotics Market, 2023 to 2033 Market, with forecasts for Action Mechanism, Drug Class, Gender, Age Group, and Route of Administration, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 30 key national markets – See forecasts for the Antibiotics Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 16 of the major companies involved in the Antibiotics Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Antibiotics Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

■ 英語タイトル：Meningococcal Vaccines Market Report 2023-2033 : Forecasts by Vaccine Type (Conjugate, Polysaccharide, Others), by Vaccine Brand (Bexsero, Menactra, Menveo, Others), by End-users (Pediatric, Adult, Travelers) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis
	■ 発行会社/調査会社：visiongain ■ 商品コード：VGA23FB017 ■ 発行日：2023年1月31日 ■ 調査対象地域：グローバル ■ 産業分野：医薬品 ■ ページ数：214 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

The Meningococcal Vaccines Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Prevalence of Meningitis Driving Market Growth
Increasing adoption of meningococcal vaccines and the growing prevalence of meningitis and other viral diseases in developed as well as developing regions is anticipated to drive market growth. Also, the growing investment in R&D and novel drug launches for the treatment of viral diseases is further boosting the market growth. The developed regions including the U.S., Japan, and Europe accounted for a large share in the market is due to the well-developed healthcare infrastructure and better healthcare awareness in developed countries compared to developing countries. Thus, the demand for advanced and more efficient drugs is high in these regions. Whereas the market in emerging economies such as China, India, and South Africa is growing at a high pace owing to government initiatives, growing respiratory health awareness, and increasing disposable income.

What Questions Should You Ask before Buying a Market Research Report?
• How is the meningococcal vaccines market evolving?
• What is driving and restraining the meningococcal vaccines market?
• How will each meningococcal vaccines submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each meningococcal vaccines submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading meningococcal vaccines markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the meningococcal vaccines projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
meningococcal vaccines projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the meningococcal vaccines market?
• Where is the meningococcal vaccines market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the meningococcal vaccines market today, and over the next 10 years:
• Our 214-page report provides 83 tables and 132 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the meningococcal vaccines market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Vaccine Type
• Conjugate
• Polysaccharide
• Others

Vaccine Brand
• Bexsero
• Menactra
• Menveo
• Others

End-users
• Pediatric
• Adult
• Travelers

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Meningococcal Vaccines Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• BIO-MED
• GSK plc
• Incepta Pharmaceuticals Ltd.
• Merck & Co., Inc.
• Pfizer Inc.
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Walvax Biotechnology Co., Ltd.
• Zhi Fei Biological

Overall world revenue for Meningococcal Vaccines Market, 2023 to 2033 in terms of value the market will surpass US$3,443.4 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Meningococcal Vaccines Market, 2023 to 2033 report help you?
In summary, our 210+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Meningococcal Vaccines Market, 2023 to 2033 Market, with forecasts for Vaccine Type, Vaccine Brand, and End-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 21 key national markets – See forecasts for the Meningococcal Vaccines Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 9 of the major companies involved in the Meningococcal Vaccines Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Meningococcal Vaccines Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

■ 英語タイトル：Clinical Trial Supplies Market Report 2023-2033 : Forecasts by Location (Offshore Clinical Site, Domestic Clinical Site), by Type (Small Molecule Products, Biologic Products, Medical Devices), by Services (Manufacturing (IMPs and INDs, Placebos, Assays and Test Kits, Others), Logistics & Distribution (Cold Chain Distribution, Non-cold Chain), Storage & Retention, Packaging and Labelling, Comparator Sourcing, Other), by Therapeutic Areas (Oncology, CNS and Mental Disorders, Cardiovascular Disease (CVD), Infectious Disease, Immunology Disease, Blood Disorders, Metabolic Disorders, Digestive Disorders, Other), by Phase (Phase-I, Phase-II, Phase-III, Phase-IV), by End-user (Contract Research Organisations, Pharmaceutical and Biotechnology Companies, Medical Device Companies, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

■ 発行会社/調査会社：visiongain ■ 商品コード：VGA23FB005 ■ 発行日：2023年1月31日 ■ 調査対象地域：グローバル ■ 産業分野：医薬品 ■ ページ数：423 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

The Clinical Trial Supplies Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Demand for Clinical Trial Outsourcing is driving the Demand for Clinical Trial Supplies Market
Downsizing and cost-cutting are important factors for large and mid-size pharmaceutical companies to outsource clinical trials, as CRO expertise in a specific therapeutic in a market where the company lacks experience with regulatory processes, operational expertise, and the ability to use manpower for other activities at the time of increasing workload. Furthermore, due to the increasing process complexity and cost of clinical studies, pharmaceutical manufacturers have been forced to outsource clinical trial supplies and supply them to research sites for reducing cost and time. Clinical supply firms are concentrating on data sharing to assist them build a solid supply chain for clinical consumables during clinical trials. This factor will have a favourable impact on the revenue growth of the clinical trial supplies market throughout the forecast period.

Unavailability of Storage Facilities in across Multiple Nations May Hamper the Expansion Clinical Trial Supplies Market
Certain clinical materials must be stored under specific climatic conditions, and such facilities are critical before conducting clinical studies. However, in countries such as Mexico, Brazil, and others, lack of clinical supply storage facilities and infrastructure may impede market acceptance of clinical trial supplies services. It is critical, for example, to determine early on if important components of the cold chain must be held in controlled temperature facilities if things are stored. Transportation of clinical supplies from cold storage to clinical sites is difficult, which is projected to limit revenue growth in this market to some extent.

What Questions Should You Ask before Buying a Market Research Report?
• How is the clinical trial supplies market evolving?
• What is driving and restraining the clinical trial supplies market?
• How will each clinical trial supplies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each clinical trial supplies submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading clinical trial supplies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the clinical trial supplies projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of clinical trial supplies projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the clinical trial supplies market?
• Where is the clinical trial supplies market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial supplies market today, and over the next 10 years:
• Our 423-page report provides 187 tables and 272 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trial supplies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial supplies prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Location
• Offshore Clinical Site
• Domestic Clinical Site

Type
• Small Molecule Products
• Biologic Products
• Medical Devices

Services
• Manufacturing
– IMPs and INDs
– Placebos
– Assays and Testkits
– Others
• Logistics & Distribution
– Cold Chain Distribution
– Non-cold Chain
• Storage & Retention
• Packaging and Labeling
• Comparator Sourcing
• Other CTS Services

Therapeutic Areas
• Oncology
• CNS and Mental Disorders
• Cardiovascular Disease (CVD)
• Infectious Disease
• Immunology Disease
• Blood Disorders
• Metabolic Disorders
• Digestive Disorders
• Other Therapeutic Areas

Phase
• Phase-I
• Phase-II
• Phase-III
• Phase-IV

End-User
• Contract Research Organizations
• Pharmaceutical and Biotechnology Companies
• Medical Device Companies
• Other End-Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 23 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• South Africa
• Saudi Arabia
• Turkey
• UAE
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trial Supplies Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• ADAllen Pharma
• AmerisourceBergen Corporation
• Ancillare
• Biocair
• Catalent, Inc.
• Clinigen Group plc
• Coghlan Group
• COREX Logistics
• DHL
• Durbin
• Endpoint Clinical
• Eurofins Scientific SE
• Inizio (UDG Healthcare plc)
• IQVIA Inc.
• KLIFO
• Liveo Research
• Lonza
• Marken (A UPS Company)
• Movianto
• Myonex
• N-SIDE
• Parexel
• PCI Pharma Services
• Piramal Pharma Solutions
• Recipharm AB
• Rubicon Research Pvt S.A.
• Seveillar Clinical Supplies Services
• Sharp Corporation
• SIRO Clinpharm
• Thermo Fisher Scientific Inc.

Overall world revenue for Clinical Trial Supplies Market, 2023 to 2033 in terms of value the market will surpass US$ 2,819.2 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Clinical Trial Supplies Market, 2023 to 2033 report help you?
In summary, our 420+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Clinical Trial Supplies Market, 2023 to 2033, with forecasts for location, type, services, therapeutic areas, phase, and end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 19 key national markets – See forecasts for the Clinical Trial Supplies Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 30 of the major companies involved in the Clinical Trial Supplies Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Clinical Trial Supplies Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.